TRCT
IVF

Tower Research Capital (TRC)’s INVO Fertility Inc IVF Stock Holding History

Tower Research Capital (TRC)’s Portfolio IVF Stock Details IVF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-700
Closed -$2.63K – 5674
2025
Q4 		$2.63K Buy
700
+640
+1,067% +$11.2K ﹤0.01% 4492
2025
Q3 		$1.83K Buy
60
+32
+114% +$2.04K ﹤0.01% 4724
2025
Q2 		$2.96K Buy
28
+22
+367% +$4.59K ﹤0.01% 4572
2025
Q1 		$1.48K Buy
6
+3
+100% +$1.77K ﹤0.01% 4701
2024
Q4 		$3.16K Sell
3
-1
-25% -$1.2K ﹤0.01% 4700
2024
Q3 		$3.62K Hold
4
– – ﹤0.01% 4810
2024
Q2 		$4.29K Sell
4
-1
-20% -$1.37K ﹤0.01% 4794
2024
Q1 		$7.82K Buy
5
+2
+67% +$3.05K ﹤0.01% 4127
2023
Q4 		$6.68K Buy
3
+1
+50% +$1.87K ﹤0.01% 4712
2023
Q3 		$2.12K Buy
+2
New +$6.32K ﹤0.01% 5210
2023
Q2 		– Hold
0
– – – 5291
2023
Q1 		– Hold
0
– – – 4901
2022
Q4 		– Hold
0
– – – 5090
2022
Q3 		– Hold
0
– – – 4384
2022
Q2 		– Hold
0
– – – 4599
2022
Q1 		– Hold
0
– – – 4781
2021
Q4 		– Hold
0
– -$3K – 6650
2021
Q3 		– Hold
0
– – – 5158
2021
Q2 		– Hold
0
– – – 5088
2021
Q1 		– Hold
0
– – – 4937

Other funds holding IVF

Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Tower Research Capital (TRC)'s IVF Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of INVO Fertility Inc (IVF) in Q1 2026, closing a stake of 700 shares — an estimated $2.63K sold.

Tower Research Capital (TRC) first reported a position in IVF in Q3 2023 and held it in 10 quarters. The position peaked at $7.82K in Q1 2024. 8 funds tracked by Wall St. Rank hold IVF as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining INVO Fertility Inc position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 700 INVO Fertility Inc shares in Q1 2026, an estimated $2.63K.
  • Tower Research Capital (TRC) first reported a position in INVO Fertility Inc in Q3 2023 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s INVO Fertility Inc position peaked at $7.82K in Q1 2024.
  • 8 funds tracked by Wall St. Rank held INVO Fertility Inc as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.